- Home
- MHK vs QGEN Comparison
MHK vs QGEN Comparison
Compare MHK & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- QGEN
- Stock Information
- Founded
- MHK 1988
- QGEN 1986
- Country
- MHK United States
- QGEN Netherlands
- Employees
- MHK N/A
- QGEN N/A
- Industry
- MHK Home Furnishings
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MHK Consumer Discretionary
- QGEN Health Care
- Exchange
- MHK Nasdaq
- QGEN Nasdaq
- Market Cap
- MHK 8.8B
- QGEN 9.5B
- IPO Year
- MHK 1992
- QGEN 1996
- Fundamental
- Price
- MHK $125.19
- QGEN $45.15
- Analyst Decision
- MHK Buy
- QGEN Buy
- Analyst Count
- MHK 13
- QGEN 9
- Target Price
- MHK $159.23
- QGEN $51.42
- AVG Volume (30 Days)
- MHK 636.6K
- QGEN 838.6K
- Earning Date
- MHK 02-06-2025
- QGEN 02-04-2025
- Dividend Yield
- MHK N/A
- QGEN 2.90%
- EPS Growth
- MHK N/A
- QGEN N/A
- EPS
- MHK 8.85
- QGEN 0.41
- Revenue
- MHK $10,812,015,000.00
- QGEN $1,966,174,000.00
- Revenue This Year
- MHK N/A
- QGEN $2.78
- Revenue Next Year
- MHK $1.95
- QGEN $5.69
- P/E Ratio
- MHK $14.32
- QGEN $109.45
- Revenue Growth
- MHK N/A
- QGEN 0.62
- 52 Week Low
- MHK $96.28
- QGEN $39.03
- 52 Week High
- MHK $164.29
- QGEN $47.44
- Technical
- Relative Strength Index (RSI)
- MHK 29.62
- QGEN 59.71
- Support Level
- MHK $124.36
- QGEN $43.30
- Resistance Level
- MHK $133.00
- QGEN $46.08
- Average True Range (ATR)
- MHK 3.03
- QGEN 0.64
- MACD
- MHK -0.60
- QGEN 0.15
- Stochastic Oscillator
- MHK 4.87
- QGEN 55.98
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).